Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

被引：95

作者：

Ganatra, Sarju ^{[1
,2
,5
]}

Redd, Robert ^{[3
]}

Hayek, Salim S. ^{[6
]}

Parikh, Rohan ^{[1
]}

Azam, Tariq ^{[6
]}

Yanik, Gregory A. ^{[7
]}

Spendley, Lauren ^{[4
]}

Nikiforow, Sarah ^{[4
]}

Jacobson, Caron ^{[4
]}

Nohria, Anju ^{[2
,5
]}

机构：

[1] Lahey Hosp & Med Ctr, Dept Med, Div Cardiovasc Med, Burlington, MA USA

[2] Dana Farber Canc Inst, Adult Canc Survivorship Program, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA

[5] Brigham & Womens Hosp, Div Cardiovasc Med, Cardiooncol Program, 75 Francis St, Boston, MA 02115 USA

[6] Univ Michigan, Div Cardiol, Ann Arbor, MI 48109 USA

[7] Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA

来源：

CIRCULATION | 2020年 / 142卷 / 17期

关键词：

axicabtagene ciloleucel; chimeric antigen receptor T-cell therapy; cardiomyopathy; cardiotoxicity; cytokine release syndrome; heart failure; lymphoma; non-Hodgkin; receptors; chimeric antigen; tisagenlecleucel;

D O I：

10.1161/CIRCULATIONAHA.120.048100

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1687 / 1690

页数：4

共 5 条

[1] Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) [J].

Alvi, Raza M. ;

Frigault, Matthew J. ;

Fradley, Michael G. ;

Jain, Michael D. ;

Mahmood, Syed S. ;

Awadalla, Magid ;

Lee, Dae Hyun ;

Zlotoff, Daniel A. ;

Zhang, Lili ;

Drobni, Zsofia D. ;

Hassan, Malek Z. O. ;

Bassily, Emmanuel ;

Rhea, Isaac ;

Ismail-Khan, Roohi ;

Mulligan, Connor P. ;

Banerji, Dahlia ;

Lazaryan, Aleksandr ;

Shah, Bijal D. ;

Rokicki, Adam ;

Raje, Noopur ;

Chavez, Julio C. ;

Abramson, Jeremy ;

Locke, Frederick L. ;

Neilan, Tomas G. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (25) :3099-3108

[2] 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial [J].

Cameron, David ;

Piccart-Gebhart, Martine J. ;

Gelber, Richard D. ;

Procter, Marion ;

Goldhirsch, Aron ;

de Azambuja, Evandro ;

Castro, Gilberto, Jr. ;

Untch, Michael ;

Smith, Ian ;

Gianni, Luca ;

Baselga, Jose ;

Al-Sakaff, Nedal ;

Lauer, Sabine ;

McFadden, Eleanor ;

Leyland-Jones, Brian ;

Bell, Richard ;

Dowsett, Mitch ;

Jackisch, Christian .

LANCET, 2017, 389 (10075) :1195-1205

[3] Current concepts in the diagnosis and management of cytokine release syndrome [J].

Lee, Daniel W. ;

Gardner, Rebecca ;

Porter, David L. ;

Louis, Chrystal U. ;

Ahmed, Nabil ;

Jensen, Michael ;

Grupp, Stephan A. ;

Mackall, Crystal L. .

BLOOD, 2014, 124 (02) :188-195

[4] Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma [J].

Linette, Gerald P. ;

Stadtmauer, Edward A. ;

Maus, Marcela V. ;

Rapoport, Aaron P. ;

Levine, Bruce L. ;

Emery, Lyndsey ;

Litzky, Leslie ;

Bagg, Adam ;

Carreno, Beatriz M. ;

Cimino, Patrick J. ;

Binder-Scholl, Gwendolyn K. ;

Smethurst, Dominic P. ;

Gerry, Andrew B. ;

Pumphrey, Nick J. ;

Bennett, Alan D. ;

Brewer, Joanna E. ;

Dukes, Joseph ;

Harper, Jane ;

Tayton-Martin, Helen K. ;

Jakobsen, Bent K. ;

Hassan, Namir J. ;

Kalos, Michael ;

June, Carl H. .

BLOOD, 2013, 122 (06) :863-871

[5] Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock [J].

Pathan, N ;

Hemingway, CA ;

Alizadeh, AA ;

Stephens, AC ;

Boldrick, JC ;

Oragui, EE ;

McCabe, C ;

Welch, SB ;

Whitney, A ;

O'Gara, P ;

Nadel, S ;

Relman, DA ;

Harding, SE ;

Levin, M .

LANCET, 2004, 363 (9404) :203-209

← 1 →